Cite
3: Targeting PPAR Signaling to Reverse Lymphedema Secondary to Cancer Treatment.
MLA
Kwan, Jennifer Yin Yee, et al. “3: Targeting PPAR Signaling to Reverse Lymphedema Secondary to Cancer Treatment.” Radiotherapy & Oncology, vol. 163, Oct. 2021, pp. S4–5. EBSCOhost, https://doi.org/10.1016/S0167-8140(21)08802-2.
APA
Kwan, J. Y. Y., Bissey, P. A., Shi, W., Williams, J., Haykal, S., Haibe-Kains, B., Yip, K. W., & Liu, F.-F. (2021). 3: Targeting PPAR Signaling to Reverse Lymphedema Secondary to Cancer Treatment. Radiotherapy & Oncology, 163, S4–S5. https://doi.org/10.1016/S0167-8140(21)08802-2
Chicago
Kwan, Jennifer Yin Yee, Pierre Antoine Bissey, Wei Shi, Justin Williams, Siba Haykal, Benjamin Haibe-Kains, Kenneth W. Yip, and Fei-Fei Liu. 2021. “3: Targeting PPAR Signaling to Reverse Lymphedema Secondary to Cancer Treatment.” Radiotherapy & Oncology 163 (October): S4–5. doi:10.1016/S0167-8140(21)08802-2.